
Your blood pressure pill may look fine in the bottle, but it might not be dissolving inside your body — and that changes everything about whether it actually works.
Quick Take
- The Food and Drug Administration (FDA) announced a nationwide recall of 11,460 bottles of chlorthalidone, a common blood pressure drug, in June 2026.
- Manufacturer Inventia Healthcare Limited voluntarily recalled the pills after tests showed they failed to dissolve correctly — meaning patients may not get their full dose.
- The recall covers 25 mg tablets in 100- and 1,000-tablet bottles from two specific batch codes: RISA24001 and ISB24002.
- The FDA has not assigned a risk class to this recall, leaving patients without clear guidance on what to do next.
What Failing Dissolution Actually Means for Your Health
A pill that does not dissolve correctly is not just a manufacturing footnote. Chlorthalidone works by helping your kidneys remove excess fluid, which lowers blood pressure. If the tablet does not break down properly after you swallow it, your body cannot absorb the full dose.
For someone managing high blood pressure, that gap in medication could mean blood pressure stays dangerously high without any obvious warning sign. You feel fine. You are not fine.
Inventia Healthcare Limited started the recall on June 5, 2026. The affected product is sold under the name Chlalid Tablets 25 mg and was distributed across the United States by Rising Pharma Holdings Inc. [1]
The FDA posted the recall notice, but as of this writing, no official risk class — Class I, II, or III — has been assigned. That missing label matters. Class I means a product could cause serious harm or death.
Class II means harm is possible but reversible. Class III means a violation exists but harm is unlikely. Without that label, patients are left guessing how worried to be. [2]
How to Check If Your Bottles Are Part of This Recall
Check the lot number printed on your bottle’s label. The two recalled batch codes are RISA24001 and ISB24002. If your bottle matches either code, contact your pharmacist right away.
Do not just stop taking the medication on your own. Stopping a blood pressure drug suddenly can cause its own set of problems. Your pharmacist can check the FDA’s Enforcement Report Index, which is updated weekly and lists all active recalls with batch-level details. [3]
The FDA’s general guidance says that consumers who spot a recalled medication should check the lot number and then talk to their doctor or pharmacist. That advice is technically correct but frustratingly thin. There are no step-by-step return instructions in the public recall notice, no list of symptoms to watch for, and no hotline number.
For a patient who takes this pill every day to manage a serious condition, “talk to your doctor” is not a complete answer. The FDA can and should do better on consumer communication. [4]
This Recall Fits a Pattern That Should Alarm Every Pill-Taker
Dissolution failures are not rare. Quality assurance problems like this one account for nearly half of all FDA drug recalls. [11] In fact, the FDA’s own best practices training materials list failed dissolution specifications as the number one reason for recalls over a recent three-year stretch. [13] That is a striking fact most people never hear.
The system catches these failures, which is good. But the volume of failures suggests the manufacturing pipeline has a persistent quality problem that deserves more public attention than it gets.
An Indian company is voluntarily recalling more than 11,000 bottles of blood pressure medication.
The recall applies to 100- and 1,000-tablet bottles of Chlorthalidone sold nationwide because they "failed dissolution specifications," according to the Food and Drug… pic.twitter.com/nPMuZ0ZaMh
— WAVY TV 10 (@WAVY_News) June 23, 2026
Most drug recalls are voluntary. A manufacturer finds a problem, reports it, and pulls the product. That is how this recall worked, and it is actually how the system is supposed to function.
The FDA cannot force a recall in most cases — it can only request one. [10] Inventia’s decision to come forward is the right move. But it also means the public is relying on manufacturers to police themselves.
That is a reasonable structure only when manufacturers act quickly and honestly, and when regulators follow up with clear, timely public guidance. Right now, the guidance side of this recall is falling short.
What You Should Do Right Now If You Take Chlorthalidone
Pull out your bottle and look at the lot number. If it reads RISA24001 or ISB24002, call your pharmacist today — not tomorrow. Ask about a replacement.
Do not stop taking the drug before you have a replacement in hand, because uncontrolled high blood pressure carries real risks. If you take a different brand or a different lot number of chlorthalidone, you are not affected by this specific recall.
Stay alert, because the FDA updates its recall database weekly and new information could emerge as this situation develops.
Sources:
[1] Web – Thousands of bottles of blood pressure medication recalled nationwide
[2] Web – FDA Announces Recall of Common Blood Pressure Medication
[3] Web – FDA recalls 11,460 bottles of chlorthalidone blood pressure tablets
[4] Web – The recall applies to 100- and 1,000-tablet bottles of Chlorthalidone …
[10] Web – More than 11K bottles of blood pressure drug recalled
[11] Web – Drug Recall Report – Washington State Local Health Insurance
[13] Web – The FDA recalled 11,460 bottles of chlorthalidone tablets, USP, 25 …





















